Pine River Capital Management’s Gilead Sciences GILD Stock Holding History

Pine River Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-32,500	Closed	-$3.06M	–	680
2014 Q4	$3.06M	Sell	32,500 -2,800	-8%	-$290K	0.04%	323
2014 Q3	$3.76M	Buy	35,300 +15,800	+81%	+$1.55M	0.04%	331
2014 Q2	$1.61M	Sell	19,500 -115,800	-86%	-$9.01M	0.02%	444
2014 Q1	$9.59M	Sell	135,300 -29,700	-18%	-$2.33M	0.15%	171
2013 Q4	$12.4M	Sell	165,000 -45,200	-22%	-$3.15M	0.15%	168
2013 Q3	$13.2M	Buy	210,200 +85,400	+68%	+$5.1M	0.14%	144
2013 Q2	$6.4M	Buy	+124,800	New	+$6.5M	0.09%	199

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pine River Capital Management's GILD Position: Q4 2016 in Review

Pine River Capital Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 9,039 shares — an estimated $715K sold.

Pine River Capital Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $10.1M in Q1 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Pine River Capital Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Pine River Capital Management sold 9,039 Gilead Sciences shares in Q4 2016, an estimated $715K.
Pine River Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Pine River Capital Management's Gilead Sciences position peaked at $10.1M in Q1 2014.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.